Teleflex Inc. Secures $200 Million Additional Loan Commitments Through Credit Agreement Amendment to Fund Strategic Acquisition

Reuters
30 Jun
Teleflex Inc. Secures $200 Million Additional Loan Commitments Through Credit Agreement Amendment to Fund Strategic Acquisition

Teleflex Inc., a leading medical technology company, has amended its Third Amended and Restated Credit Agreement dated November 4, 2022. The amendment, finalized on June 24, 2025, introduces additional delayed draw term loan commitments amounting to $200 million. This enhances the company's Delayed Draw Term Loan Facility to a total of $700 million, supporting its planned acquisition of the Vascular Intervention business segment from MS Holding II SE. The terms of the facility remain largely unchanged, ensuring continued financial flexibility for Teleflex's strategic growth initiatives.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teleflex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000096943-25-000107), on June 30, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10